Co-administration of 5a-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids. (2020)
Attributed to:
Dissecting the steroid metabolome in the pathogenesis and treatment of metabolic liver disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgaa408
PubMed Identifier: 32594135
Publication URI: http://europepmc.org/abstract/MED/32594135
Type: Journal Article/Review
Volume: 105
Parent Publication: The Journal of clinical endocrinology and metabolism
Issue: 9
ISSN: 0021-972X